In today’s briefing:
- Kingston Financial (1031 HK): What Will Chu Choose To Do?
- EQD | FXI (FXI US): – Could Chinese Equities Lead the Way Higher? Use Options for Delta
- Shanghai/Shenzhen Northbound Connect: Weekly Moves (14 October 2022)
- Weekly Wrap – 14 Oct 2022
- Shanghai/Shenzhen Southbound Connect: Weekly Moves (14 October 2022)
- Giant Biogene IPO: Strong Growth Prospects Offsets Short-Term Margin Concerns
Kingston Financial (1031 HK): What Will Chu Choose To Do?
- Hong Kong brokerage Kingston Financial (1031 HK) was suspended this morning pursuant to Hong Kong’s Takeovers Code.
- Chu Yuet Wah is the largest shareholder with 74.6% of shares out.
- Shares are down 98% from the January 2018 peak. A chunky premium may be on the cards if a firm Offer unfolds.
EQD | FXI (FXI US): – Could Chinese Equities Lead the Way Higher? Use Options for Delta
- 20th National Congress of the Communist Party is due to kick off this week
- Will economic growth be top of the agenda and is there any scope to adjust the Covid strategy?
- With many potential growth factors, use derivatives to gain delta exposure
Shanghai/Shenzhen Northbound Connect: Weekly Moves (14 October 2022)
- Inside is a recap of movements in the last week relating to the Hong Kong Stock Exchange -Shanghai and Shenzhen Northbound Connect facilities, broken down by company and industry.
- Overall, net outflow over the past week was ~US$1.8bn, split between Shanghai (-US$2.0bn) and Shenzhen (+US$0.20bn).
- The largest inflows were into Satellite Chemical (002648 CH) and CATL (A) (300750 CH). The largest outflows were in Kweichow Moutai (600519 CH) and China Merchants Bank A (600036 CH).
Weekly Wrap – 14 Oct 2022
Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.
In this Insight:
and more…
Shanghai/Shenzhen Southbound Connect: Weekly Moves (14 October 2022)
- Inside is a recap of movements in the last week relating to the Shanghai and Shenzhen-Hong Kong Stock Connect facilities, broken down by company and industry.
- Overall, the net inflow over the past week was ~US$0.5bn, split (+US$0.26bn) for Shanghai and (+US$0.24bn) for Shenzhen.
- The largest inflows were into Tracker Fund of Hong Kong Ltd (2800 HK) and Tencent (700 HK). The largest outflows were in Meituan (3690 HK) and Semiconductor Manufacturing International (981 HK).
Giant Biogene IPO: Strong Growth Prospects Offsets Short-Term Margin Concerns
- Giant Biogene Holding (GBH HK) designs, develops and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient in China.
- The company has filed for an IPO on the Hong Kong Stock Exchange and plans to raise proceeds of around HK$500m.
- We remain positive on Biogene’s growth prospects as it operates in a growing market which should further benefit from regulatory tailwinds.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars